Medtronic views Stealth Axis as the ‘cornerstone’ of AiBLE, the company’s surgical workflow ecosystem.

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS™ surgical system for cranial and ear, nose, and ...

Medtronic (NYSE:MDT) announced today that the FDA cleared its Stealth AXiS surgical robotic system for new indications.

The surgical navigation and robotics system is part of the company’s push to expand its share of the $15 billion cranial and spinal technologies market.

In late March 2026, Medtronic received FDA clearance for its Stealth AXiS surgical system to be used in cranial and ENT procedures, extending its earlier spine-focused approval and unifying AI-enabled ...

Tim Shannon, vice president of operations for Blue Chip Surgical Center Partners, discusses 10 ways surgery centers can profit from ENT while improving patient safety and satisfaction. 1. Ensure ...

The reimbursement rates for many ASC procedures have benefited and will benefit under the new Medicare payment system. One such procedure seeing a noticeable reimbursement boost is endoscopy with ...

Department of the Korle Bu Teaching Hospital has performed a surgical operation that is aimed at restoring the hearing ...

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration ...

US FDA clears Medtronic’s Stealth AXiS surgical system for cranial and ENT procedures: Galway, Ireland Monday, March 30, 2026, 10:00 Hrs [IST] Medtronic, a global leader in heal ...